Innovent Biologics, Inc. (HKG:1801)

Innovent Biologics Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 29, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	168,294	59,956	69,333	51,403	70,547	115,098
Market Cap Growth	-13.53%	-13.53%	34.88%	-27.14%	-38.71%	243.36%
Enterprise Value	162,917	54,283	63,850	44,899	59,352	109,367
Last Close Price	98.45	36.60	42.75	33.50	48.25	82.05
PS Ratio	16.78	5.98	10.14	9.98	13.46	25.21
PB Ratio	12.06	4.30	5.02	4.24	5.56	11.04
P/TBV Ratio	12.35	4.40	5.04	4.25	5.57	11.04
P/FCF Ratio	492.11	175.32	-	-	-	-
P/OCF Ratio	122.88	43.78	425.78	-	-	-
EV/Sales Ratio	16.25	5.41	9.34	8.72	11.33	23.96
EV/EBITDA Ratio	-	2126.28	-	-	-	-
EV/FCF Ratio	476.39	158.73	-	-	-	-
Debt / Equity Ratio	0.22	0.22	0.29	0.30	0.24	0.14
Debt / EBITDA Ratio	50.93	50.93	-	-	-	-
Debt / FCF Ratio	8.81	8.81	-	-	-	-
Asset Turnover	0.45	0.45	0.33	0.27	0.30	0.40
Inventory Turnover	2.69	2.69	1.51	1.00	1.19	1.45
Quick Ratio	2.08	2.08	2.68	2.78	3.27	5.85
Current Ratio	2.35	2.35	3.00	3.29	3.79	6.37
Return on Equity (ROE)	-0.74%	-0.74%	-8.84%	-20.70%	-28.56%	-14.75%
Return on Assets (ROA)	-0.82%	-0.82%	-5.12%	-11.54%	-12.04%	-3.65%
Return on Capital (ROIC)	-1.08%	-1.08%	-6.49%	-14.57%	-14.81%	-4.46%
Earnings Yield	-0.06%	-0.17%	-1.63%	-4.79%	-4.75%	-1.03%
FCF Yield	0.20%	0.57%	-1.54%	-6.19%	-5.38%	-0.82%
Buyback Yield / Dilution	-4.35%	-4.35%	-4.67%	-2.37%	-7.27%	-15.23%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.